prostate cancer patients

(Wiley-Blackwell) 91 percent of men who have a prostate cancer operation can retain their ability to orgasm if the surgery is carried out without removing both sets of nerves that surround the prostate gland like a hammock.

American researchers who studied 408 patients who received robot-assisted laparoscopic radical prostatectomy found this figure went down to 82 percent if one side was removed and 61 percent if there was little or no nerve sparing.

(Thomas Jefferson University) Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy, a study from researchers at Jefferson's Kimmel Cancer Center suggests.

Opting to track, not treat, early prostate cancer Associated Press

(ECCO-the European CanCer Organisation) Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult.

Now the first large randomized Phase III trial of a bisphosphonate drug in these patients has shown that a single dose of the drug is as good for pain relief as single dose radiotherapy, the standard treatment for bone metastases.

This research will be presented on Sept. 25 at the 2011 European Multidisciplinary Cancer Congress.

Share:

(Mayo Clinic) Long-term survival rates for patients with advanced prostate cancer suggest they can be good candidates for surgery, Mayo Clinic researchers have found.

(Uppsala University) A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years.

The study found, among other things, that surgery reduces the risk that men with prostate cancer (even those with low-risk tumors) will die within 15 years.

The results were published today in the New England Journal of Medicine.

(Thomas Jefferson University) A widely-available yet expensive radiotherapy technique used to treat prostate cancer patients after surgery has promising benefits -- higher dose and less damage to the rectum and bladder -- compared to a less precise technique, Thomas Jefferson University researchers document for the first time in a new study published in Practical Radiation Oncology.

(Wiley-Blackwell) 70 percent men who received androgen-deprivation therapy (ADT) after surgery to remove their prostate gland gained significant weight in the first year, putting on an average of 4.2kg.

Researchers studied the recorded weights of 132 men who underwent radical prostatectomy between 1988 and 2009 at four US Veterans Affairs Medical Centers in California, Georgia and North Carolina, before and after they received ADT.

(University of California - Los Angeles) UCLA researchers announce the successful demonstration of their 2nd-generation CTC enrichment technology, capable of effectively identifying and capturing circulating tumor cells (CTCs) in blood samples collected from prostate cancer patients.

This new approach could be even faster and cheaper than existing methods and captures a greater number of CTCs.